October 08, 2021
COVID-19 Is Reshaping Global Pharmaceutical Competition – to Asia’s Benefit
By Hannah Elyse Sworn
The valuable experience gained by Asian companies during the pandemic could upset the West’s monopoly in high-value drugs more generally, with implications for global access to medicines.
February 24, 2021
Japan’s Struggle for a Home-Grown COVID-19 Vaccine
By Thisanka Siripala
Japan's lagging vaccine roll-out draws attention to the barriers in commercializing domestic vaccine production.